- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05940688
Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study (PᵌOPPY)
Study Overview
Status
Conditions
Detailed Description
Feasibility Study Aims
- To assess the feasibility of the digital health (DHI) and community health worker (CHW) interventions by assessing participant acceptance and use of the intervention.
- To assess study enrollment to determine appropriateness and usefulness of the inclusion and exclusion criteria to estimate enrollment duration in the planned trial.
- To determine the number of prenatal visits and the incidence of some of the maternal and neonatal outcomes (ones with higher prevalence) or surrogate outcomes that will be targeted in the planned factorial design randomized controlled trial. (Data will be collected on all relevant maternal and neonatal outcomes. The randomized feasibility design will allow for effect size estimates of the intervention on the incidence of maternal and neonatal outcomes, which will aid in determining the appropriate target outcomes as well as power calculation of the more definitive trial.)
The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The promise of digital health and community health worker engagement makes PᵌOPPY interventions potentially transformative, sustainable, and scalable for Non-Hispanic Black mothers and their infants from under-served communities in Alabama and beyond. The objective of this pilot study is to determine if it is feasible to randomize and implement digital health and community health worker interventions.
Design Summary
The investigators will challenge existing care paradigms by testing the effectiveness of integrating innovative platforms into the existing healthcare system, including existing digital health and community health worker programs from within the EQUATE consortium, to eliminate critical barriers to equitable healthcare access. After seeking input from a Community Advisory Board, these interventions will be refined and deployed for pilot testing. Individuals in Non-Hispanic Black communities at the highest risk of adverse pregnancy outcomes which were historically underrepresented in clinical research due to structural racism will be included. The investigative team employs experts across the community, maternal, and infant health continuum.
For this pilot, 40 eligible participants will be randomized, 10 to usual care, 10 to DHI, 10 to CHW, and 10 to DHI + CHW
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rosylen "Roz" Quinney
- Phone Number: 205.934.1309
- Email: p3oppy@uabmc.edu
Study Contact Backup
- Name: Wally Carlo, MD
- Phone Number: 205.934.5611
- Email: wacarlo@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Rachel Sinkey
- Phone Number: 205-934-5611
- Email: rsinkey@uabmc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self Identifies as Non-Hispanic Black
- Between 16-49 years old
- Pregnant individuals between 8⁰ - 22⁶ weeks gestational age
- Live singleton or dichorionic twin gestation
- Dating sonogram at <23 weeks gestation
- Area Deprivation Index (ADI) National 4th or 5th Quintile
- Planning to deliver at UAB Hospital
- Speaks and writes in English
- No indication for delivery at the time of enrollment
Exclusion Criteria:
- Declines randomization
- Speaks or writes in languages other than English
- Currently incarcerated
- Fetal demise diagnosed prior to enrollment
- Known major structural chromosomal abnormalities prior to enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Digital Health Intervention
This group will receive routine prenatal care services.
Additionally, those randomized to this arm will receive a DHI intervention.
A modified DHI will be utilized that was developed by Memora Health in conjunction with EQUATE partners at UPenn and feedback from the POPPY Study Team and Community Advisory Board.
All content is designed for 7th grade Flesch-Kincaid level or lower.
|
Health care information delivered via a link in a text message that is then opened in a secure browser.
Other Names:
|
Experimental: Community health worker (CHW)
Individuals randomized to this group will receive routine prenatal care services.
Additionally, they will receive a CHW intervention.
The CHW intervention will be adapted from an ongoing CHW program in Jefferson County, AL called "From Day One (FDO)", a comprehensive patient-centered program designed to educate and provide non-clinical, psychosocial, emotional support to expectant mothers from the 1st trimester of pregnancy through their child's first year of life.
The intervention has been modified by the POPPY Study Team and Community Advisory Board.
|
Health care information delivered via CHW.
Other Names:
|
Experimental: DHI Plus CHW
This group will receive routine prenatal care services.
Additionally, this group will receive both DHI and CHW interventions.
|
Health care information delivered via DHI plus CHW
|
No Intervention: Usual Care
This group will receive routine prenatal care services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant acceptance of randomization arm / intervention
Time Frame: From randomization to 6 weeks postpartum
|
Participant acceptance is defined as a yes response to this question: "I would recommend the care I received to someone in a similar situation." |
From randomization to 6 weeks postpartum
|
Participant use of digital health and/or community health worker interventions
Time Frame: From randomization to 6 weeks postpartum
|
Use of the intervention for the digital health arm(s) is defined as the % of opened text messages.
Use of the intervention for the community health worker arm(s) is defined as the % of planned sessions in which the participant engages with the community health worker.
|
From randomization to 6 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outpatient Prenatal Care Visits
Time Frame: Duration of pregnancy through 6 weeks postpartum
|
Number of outpatient prenatal care and postpartum visits
|
Duration of pregnancy through 6 weeks postpartum
|
Preterm Birth
Time Frame: At birth
|
Delivery of a neonate at less than 37 weeks
|
At birth
|
Neonatal birthweight
Time Frame: At birth
|
Weight of neonate at birth
|
At birth
|
Cesarean delivery
Time Frame: At birth
|
Occurrence of a cesarean birth
|
At birth
|
Maternal blood transfusion
Time Frame: Duration of pregnancy through 6 weeks postpartum
|
Transfusion of blood products
|
Duration of pregnancy through 6 weeks postpartum
|
Breastfeeding intent
Time Frame: From randomization to delivery of the infant(s)
|
Participant's self-reported intent of whether or not to express breast milk upon admission to the delivery-associated hospitalization
|
From randomization to delivery of the infant(s)
|
Vaccination rate
Time Frame: Pregnancy through 6 weeks postpartum / 6 weeks of life
|
The number of recommended vaccinations for which the mother and newborn accepted
|
Pregnancy through 6 weeks postpartum / 6 weeks of life
|
Maternal postpartum readmission
Time Frame: From discharge from the delivery-associated hospitalization to 6 weeks postpartum
|
Admission of the mother to the hospital after discharge from the delivery-associated hospitalization
|
From discharge from the delivery-associated hospitalization to 6 weeks postpartum
|
Neonatal hospital readmission
Time Frame: Birth to 6 weeks of life
|
Admission of a neonate to the hospital after discharge from the hospital after birth
|
Birth to 6 weeks of life
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rachel Sinkey, MD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 300009897
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier René DubosCompletedDeciduitis; Complicating Pregnancy
Clinical Trials on Digital Health intervention
-
Adai Technology (Beijing) Co., Ltd.Recruiting
-
Forman Christian College, PakistanSaglik Bilimleri Universitesi; doctHERsCompleted
-
University of OsloTechnical University of Munich; National Institute for Medical Research, Tanzania and other collaboratorsCompletedHIV Infections | Tuberculosis | Cysticercosis | Tapeworm PorkTanzania
-
40FYThe Ministry of SMEs and Startups. South KoreaCompletedPersonality | Mental Health ServicesKorea, Republic of
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV Pre-Exposure ProphylaxisUnited States
-
Columbia UniversityNational Institute of Nursing Research (NINR)CompletedContraception BehaviorUnited States
-
The University of Hong KongSino Group; NG TENG FONG Charitable FoundationRecruiting
-
University of California, San FranciscoCompletedColon Cancer | Rectum CancerUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Utah State UniversityRecruitingPsychological Distress | Psychological Flexibility | Psychological Well-BeingUnited States